The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1587
December 16, 2019
View Complete Issue         Table of Contents 2019 
Annovera - A New Contraceptive Vaginal Ring
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Annovera - A New Contraceptive Vaginal Ring
December 16, 2019 (Issue: 1587)
Annovera (TherapeuticsMD), a contraceptive vaginal ring that releases segesterone acetate, a synthetic progestin, and ethinyl estradiol, was approved by the FDA in 2018 and is now available. It is the first product to contain segesterone and the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Annovera - A New Contraceptive Vaginal Ring
Article code: 1587b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.